Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Regulatory News:
In today’s interim report, Nolato (STO:NOLAB) reports strong earnings and a high return on capital for the second quarter. Sales increased by 11% to SEK 1,164 million (1,046) and operating income (EBITA) increased by 37% to SEK 111 million (81). Earnings per share increased to SEK 2.97 (2.05) and the cash flow after investments amounted to SEK 120 million (56, excluding acquisitions).
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Regulatory News:
In today’s interim report, Nolato (STO:NOLAB) reports strong earnings and a high return on capital for the second quarter. Sales increased by 11% to SEK 1,164 million (1,046) and operating income (EBITA) increased by 37% to SEK 111 million (81). Earnings per share increased to SEK 2.97 (2.05) and the cash flow after investments amounted to SEK 120 million (56, excluding acquisitions).
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
